[TREATMENT OF APOPLEXY WITH PANTHESIN-HYDERGIN].
D001565:Benzoates; D035843:Biomedical Research; D002561:Cerebrovascular Disorders; D004088:Dihydroergotoxine; D004358:Drug Therapy; D004876:Ergot Alkaloids; D007930:Leucine / Q000031:analogs & derivatives; D020521:Stroke; D014116:Toxicology; D014665:Vasodilator Agents; D062366:para-Aminobenzoates
D001565:Benzoates; D004876:Ergot Alkaloids; D014665:Vasodilator Agents; D062366:para-Aminobenzoates; D004088:Dihydroergotoxine; C005426:leucinocaine mesylate; D007930:Leucine
BENZOATES; CEREBROVASCULAR DISORDERS; CLINICAL RESEARCH; DRUG THERAPY; ERGOT ALKALOIDS, HYDROGENATED; TOXICOLOGIC REPORT; VASODILATOR AGENTS
THERAPIE DES SCHLAGANFALLS MIT PANTHESIN-HYDERGIN.